Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
33%
Ph phase_3
1
33%
Ph early_phase_1
1
33%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (33.3%)
Phase 21 (33.3%)
Phase 31 (33.3%)

Trials by Status

active_not_recruiting133%
completed133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_3

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

NCT01224288
completedphase_2

Targeted Delivery of Chemotherapy With Ultrasound and Microbublles

NCT03458975
unknownearly_phase_1

PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases

NCT01410760

Clinical Trials (3)

Showing 3 of 3 trials
NCT01224288Phase 3

Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble

Active Not Recruiting
NCT03458975Phase 2

Targeted Delivery of Chemotherapy With Ultrasound and Microbublles

Completed
NCT01410760Early Phase 1

PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases

Unknown

All 3 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
3